ClickSquared pulled in $9 million, and Boston-based DataXu acquired U.K. and Germany-based Mexad for an undisclosed sum.
—Forma Therapeutics of Watertown, MA, announced its second partnership surrounding cancer drug discovery in less than a week. This time it’s with the Johnson & Johnson unit (NYSE: [[ticker:JNJ]]) Janssen Biotech, which could pay Forma up to $700 million in development, regulatory, and commercial milestone payments if the deal generates new drugs.
—A new Cambridge-based biotech called Warp Drive Bio kicked off with the mission of tapping into substances derived from plants, animals, and other wild organisms as potential sources of new drugs. It nabbed $125 million in funding, from Third Rock Ventures, drugmaker Sanofi (NYSE: [[ticker:SNY]]), and Greylock Partners.
—On the mobile front, Boston-based Zmags pulled in $7 million from Square 1 Bank and existing backers OpenView Venture Partners and Northcap Partners. The startup offers technology for enabling brands to create and manage advertising campaigns across mobile devices, tablets, and the Web. And Verivo Software, formerly known as Pyxis Mobile, raised $17 million to put toward its tools for companies looking to develop mobile apps. Its investors were Commonwealth Capital, Egan-Managed Capital, and Ascent Venture Partners.